A successful desensitization in an adult patient with ARA-C infusion reaction.
J Oncol Pharm Pract
; 30(4): 780-782, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38545702
ABSTRACT
INTRODUCTION:
Cytarabine (ARA-C) is an antimetabolite agent used especially in the treatment of hematologic malignancies. Infusion reactions have an important place among the side effects that may occur due to treatment. Clinical findings of infusion reactions resemble allergic reactions. CASE REPORT 47-year-old male patient with a diagnosis of B-cell Acute Lymphoblastic Leukaemia developed infusion reaction during ARA-C treatment. MANAGEMENT &OUTCOME:
There was no alternative treatment option for his existing malignant disease, we decided ARA-C desensitization.DISCUSSION:
We would like to describe a successful desensitization protocol in an adult patient who experienced a reaction during ARA-C infusion.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Desensitization, Immunologic
/
Cytarabine
/
Drug Hypersensitivity
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Oncol Pharm Pract
/
J. oncol. pharm. pract. (Online)
/
Journal of oncology pharmacy practice (Online)
Journal subject:
FARMACIA
Year:
2024
Document type:
Article
Country of publication:
Reino Unido